aTyr Pharma, Inc. ( ATYR) - Key Metrics
ATYR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.11 | -$0.10 | -$0.10 |
| 2026Q1 | $0 | -$0.11 | -$0.13 | -$0.13 |
| 2025Q4 | $0 | -$0.14 | -$0.12 | -$0.12 |
| 2025Q3 | $0 | -$0.26 | -$0.21 | -$0.21 |
| 2025Q2 | $0 | -$0.22 | -$0.15 | -$0.15 |
ATYR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.36 |
| 2026Q1 | 0% | -1.77 |
| 2025Q4 | 0% | -1.40 |
| 2025Q3 | 0% | -0.69 |
| 2025Q2 | 0% | -5.76 |
ATYR
Price: $0.50
52 week price:
Earnings Per Share: -0.64 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 53.0 million